Conclusion(s): Although a possible link between ovulation induction drugs and the risk of ovarian carcinoma is inconclusive, one should be very cautious when prescribing ovulation induction agents.

• 结论：使用排卵药物需十分的小心，任何在诱导排卵中持续存在的卵巢肿瘤，均需仔细加以评估。